YAP1 and liver cancer: In human fibroblast cells, progressive loss of YAP promotes concomitant increase of senescence through P16 pathways in a TEAD-dependent manner; in context of cancer, the authors reported that in mesothelioma and liver cancer, YAP downregulation was also able to stimulate senescence [35].